Floatz logo

FLAVONE, 3,3',4',5,7-PENTAHYDROXY-

Myeloma Multiple

Centro de Atencion e Investigacion MedicaSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Myeloma Multiple cohort.

Asset / SponsorPhaseRating
FCH
University Hospital, Bordeaux
Phase 3BB
Eloxatin
OHSU Knight Cancer Institute
Phase 1/2CCC

Same molecule, other indications

FLAVONE, 3,3',4',5,7-PENTAHYDROXY- is also rated in:

Hepatitis B Virus InfectionDormant
BB
Indicative ·
69 / 100
View asset →
Fanconi anemiaDormant
BB
Indicative ·
64 / 100
View asset →
squamous cell carcinomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →